Medications are nutrition. That's essentially the rationale behind a couple of Big Pharma corporations' decision to give a failed Alzheimer's drug a second chance.
In short, Big Pharma wants to treat a disease even before it ever shows up. What's more, an unproven medicine, rather than nutrition, is being pushed as the most effective way to deal with Alzheimer's.
There's a better way to guard against Alzheimer's that doesn't cost billions of dollars, risk your health or drive up the cost of medications.
According to prior Alzheimer's research, evidence shows that the build-up of beta amyloid plaque is a major component of the disease. They show that high levels of beta result in neuronal cell death, according to the National Center for Biotechnology Information at Bethesda, Md. In addition, researchers have found that beta amyloids can increase in the absence of friendly endothelial nitric oxide (eNOS), which is essential to the proper function of our vascular system. While more research is needed, some studies have shown a relationship between the disease and the chemical resveratrol, which can increase eNOS and thereby lower levels of the plaque seen in Alzheimer's (resveratrol "is a natural protective compound found in high concentrations in red grapes, red wine, purple grape juice, peanuts, and some berries," wrote NaturalNews.com's John Phillip).
Since September, 16 major drug companies have inked deals with the Trump administration to lower prices....
